Pick a job to read the details
Tap any role on the left — its description and apply link will open here.
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, Commercial Lead, Germany is responsible for defining and executing the local commercial strategy for oncology products. This role is accountable for building the commercial organization, driving launch and growth performance, and ensuring strong alignment across Medical Affairs, Market Access, and other key functions.
The incumbent needs to proactively recognize and address relevant systemic (e.g. health care structures, competitors, data gaps, diagnostic challenges, missing advocacy) and HCP related opportunities (e.g. therapeutic gaps, differentiation, economical attributes, clear messaging of patient- and physician relevant benefits). The Senior Director Commercial Lead, Germany will further oversee the generation of insights from the therapeutic field, and translate these insights into a comprehensive, cross-functional strategy. Supporting a clear positioning and aligned communication approach, the incumbent will in addition secure the development and implementation of tactics and tools for the field force to effectively address customer needs.
Responsibilities:
Act as the commercial lead for Germany accountable for local commercial strategy, execution, and performance across the oncology portfolio.
Serve as a core member of the COUNTRY Leadership Team, contributing to German strategy, launch planning, and business decisions.
Partner with regional and local Medical Affairs and Marketing Team to translate clinical and economic evidence into compelling value communications tailored for German stakeholders including HCPs and payers.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements in close collaboration with the ED, Marketing, Europe.
Collaborate with regional commercial teams by representing the country and contributing to commercial plans shaping our strategy.
Develop and execute country-level brand and portfolio strategies across pre-launch, launch, and post-launch phases.
Drive demand generation and appropriate use through non-promotional and promotional channels in compliance with local regulations.
Lead forecasting, budgeting, and operational planning for the country in close collaboration with the ED, Commercial Excellence, Business Analytics and Insights, Europe.
Lead commercial launch readiness for oncology products, including customer strategy, segmentation, targeting, and field force planning.
Partner closely with Medical Affairs and Market Access to ensure integrated launch execution and consistent external engagement.
Monitor performance, competitive dynamics, and market trends, adjusting strategy as needed.
Oversee customer engagement strategy across key stakeholders, including oncologists, treatment centers, and healthcare organizations.
Ensure effective field force deployment and capability building (e.g., sales, key account management, customer-facing roles).
Work closely with Medical Affairs, Market Access, Regulatory, Finance, Corporate Affairs and other support functions to ensure aligned and compliant country execution.
Ensure strong integration of commercial plans with access, medical, and evidence strategies.
Build, lead, and develop the country commercial organization, including sales, marketing, and customer-facing roles as the business scales.
Establish commercial processes, governance, and ways of working as part of the country build-out.
Contribute to regional and country-specific initiatives.
Travel nationally and internationally.
Required Skills, Experience and Education:
Advanced degree required (e.g., ).
10+ years’ of experience in pharmaceutical or biotech commercial roles.
Significant experience in oncology commercial leadership at country level.
Proven track record of successful oncology product launches in Germany and successful HCP / KOL interactions.
Proven project management experience.
Excellent communication skills, both in person and virtual.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly preferred.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-LO1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, Commercial, UK is responsible for defining and executing the local commercial strategy for oncology products. This role is accountable for building the commercial organization, driving launch and growth performance, and ensuring strong alignment across Medical Affairs, Market Access, and other key functions.
The incumbent needs to proactively recognize and address relevant systemic (e.g. health care structures, competitors, data gaps, diagnostic challenges, missing advocacy) and HCP related opportunities (e.g. therapeutic gaps, differentiation, economical attributes, clear messaging of patient- and physician relevant benefits). The Senior Director Commercial will further oversee the generation of insights from the therapeutic field, and translate these insights into a comprehensive, cross-functional strategy. Supporting a clear positioning and aligned communication approach, the incumbent will in addition secure the development and implementation of tactics and tools for the field force to effectively address customer needs.
Responsibilities:
Act as the Commercial Lead for UK accountable for local commercial strategy, execution, and performance across the oncology portfolio.
Serve as a core member of the UK Leadership Team, contributing Italy strategy, launch planning, and business decisions.
Partner with regional and local Medical Affairs and Marketing Team to translate clinical and economic evidence into compelling value communications tailored for UK stakeholders including HCPs and payers.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements in close collaboration with the ED Marketing, Europe.
Collaborate with regional commercial teams by representing the country and contributing to commercial plans shaping our strategy.
Develop and execute country-level brand and portfolio strategies across pre-launch, launch, and post-launch phases.
Drive demand generation and appropriate use through non-promotional and promotional channels in compliance with local regulations.
Lead forecasting, budgeting, and operational planning for the country in close collaboration with the ED, Commercial Excellence, Business Analytics and Insights, Europe.
Lead commercial launch readiness for oncology products, including customer strategy, segmentation, targeting, and field force planning.
Partner closely with Medical Affairs and Market Access to ensure integrated launch execution and consistent external engagement.
Monitor performance, competitive dynamics, and market trends, adjusting strategy as needed.
Oversee customer engagement strategy across key stakeholders, including oncologists, treatment centers, and healthcare organizations.
Ensure effective field force deployment and capability building (e.g., sales, key account management, customer-facing roles).
Work closely with Medical Affairs, Market Access, Regulatory, Finance, Corporate Affairs and other support functions to ensure aligned and compliant country execution.
Ensure strong integration of commercial plans with access, medical, and evidence strategies.
Build, lead, and develop the country commercial organization, including sales, marketing, and customer-facing roles as the business scales.
Establish commercial processes, governance, and ways of working as part of the country build-out.
Foster a culture of accountability, collaboration, and performance excellence.
Contribute to regional and country-specific initiatives.
Travel nationally and internationally.
Required Skills, Experience and Education:
Advanced degree required (e.g., MSc, PhD, MD, PharmD).
10+ years of experience in pharmaceutical or biotech commercial roles.
Significant experience in oncology commercial leadership at country level.
Proven track record of successful oncology product launches in UK and successful HCP / KOL interactions.
Proven project management experience.
Excellent communication skills, both in person and virtual.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly preferred.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, Commercial, Spain is responsible for defining and executing the local commercial strategy for oncology products. This role is accountable for building the commercial organization, driving launch and growth performance, and ensuring strong alignment across Medical Affairs, Market Access, and other key functions.
The incumbent needs to proactively recognize and address relevant systemic (e.g. health care structures, competitors, data gaps, diagnostic challenges, missing advocacy) and HCP related opportunities (e.g. therapeutic gaps, differentiation, economical attributes, clear messaging of patient- and physician relevant benefits). The Senior Director Commercial will further oversee the generation of insights from the therapeutic field, and translate these insights into a comprehensive, cross-functional strategy. Supporting a clear positioning and aligned communication approach, the incumbent will in addition secure the development and implementation of tactics and tools for the field force to effectively address customer needs.
Responsibilities:
Act as the Commercial Lead for Spain accountable for local commercial strategy, execution, and performance across the oncology portfolio.
Serve as a core member of the Spain Leadership Team, contributing Spain strategy, launch planning, and business decisions.
Partner with regional and local Medical Affairs and Marketing Team to translate clinical and economic evidence into compelling value communications tailored for Spain stakeholders including HCPs and payers.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements in close collaboration with the ED Marketing, Europe.
Collaborate with regional commercial teams by representing the country and contributing to commercial plans shaping our strategy.
Develop and execute country-level brand and portfolio strategies across pre-launch, launch, and post-launch phases.
Drive demand generation and appropriate use through non-promotional and promotional channels in compliance with local regulations.
Lead forecasting, budgeting, and operational planning for the country in close collaboration with the ED, Commercial Excellence, Business Analytics and Insights, Europe.
Lead commercial launch readiness for oncology products, including customer strategy, segmentation, targeting, and field force planning.
Partner closely with Medical Affairs and Market Access to ensure integrated launch execution and consistent external engagement.
Monitor performance, competitive dynamics, and market trends, adjusting strategy as needed.
Oversee customer engagement strategy across key stakeholders, including oncologists, treatment centers, and healthcare organizations.
Ensure effective field force deployment and capability building (e.g., sales, key account management, customer-facing roles).
Work closely with Medical Affairs, Market Access, Regulatory, Finance, Corporate Affairs and other support functions to ensure aligned and compliant country execution.
Ensure strong integration of commercial plans with access, medical, and evidence strategies.
Build, lead, and develop the country commercial organization, including sales, marketing, and customer-facing roles as the business scales.
Establish commercial processes, governance, and ways of working as part of the country build-out.
Foster a culture of accountability, collaboration, and performance excellence.
Contribute to regional and country-specific initiatives.
Travel nationally and internationally.
Required Skills, Experience and Education:
Advanced degree required (e.g., MSc, PhD, MD, PharmD).
10+ years of experience in pharmaceutical or biotech commercial roles.
Significant experience in oncology commercial leadership at country level.
Proven track record of successful oncology product launches in Spain and successful HCP / KOL interactions.
Proven project management experience.
Excellent communication skills, both in person and virtual.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly preferred.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, Commercial, Italy is responsible for defining and executing the local commercial strategy for oncology products. This role is accountable for building the commercial organization, driving launch and growth performance, and ensuring strong alignment across Medical Affairs, Market Access, and other key functions.
The incumbent needs to proactively recognize and address relevant systemic (e.g. health care structures, competitors, data gaps, diagnostic challenges, missing advocacy) and HCP related opportunities (e.g. therapeutic gaps, differentiation, economical attributes, clear messaging of patient- and physician relevant benefits). The Senior Director Commercial will further oversee the generation of insights from the therapeutic field, and translate these insights into a comprehensive, cross-functional strategy. Supporting a clear positioning and aligned communication approach, the incumbent will in addition secure the development and implementation of tactics and tools for the field force to effectively address customer needs.
Responsibilities:
Act as the Commercial Lead for Italy accountable for local commercial strategy, execution, and performance across the oncology portfolio.
Serve as a core member of the Italy Leadership Team, contributing Italy strategy, launch planning, and business decisions.
Partner with regional and local Medical Affairs and Marketing Team to translate clinical and economic evidence into compelling value communications tailored for Italy stakeholders including HCPs and payers.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements in close collaboration with the ED Marketing, Europe.
Collaborate with regional commercial teams by representing the country and contributing to commercial plans shaping our strategy.
Develop and execute country-level brand and portfolio strategies across pre-launch, launch, and post-launch phases.
Drive demand generation and appropriate use through non-promotional and promotional channels in compliance with local regulations.
Lead forecasting, budgeting, and operational planning for the country in close collaboration with the ED, Commercial Excellence, Business Analytics and Insights, Europe.
Lead commercial launch readiness for oncology products, including customer strategy, segmentation, targeting, and field force planning.
Partner closely with Medical Affairs and Market Access to ensure integrated launch execution and consistent external engagement.
Monitor performance, competitive dynamics, and market trends, adjusting strategy as needed.
Oversee customer engagement strategy across key stakeholders, including oncologists, treatment centers, and healthcare organizations.
Ensure effective field force deployment and capability building (e.g., sales, key account management, customer-facing roles).
Work closely with Medical Affairs, Market Access, Regulatory, Finance, Corporate Affairs and other support functions to ensure aligned and compliant country execution.
Ensure strong integration of commercial plans with access, medical, and evidence strategies.
Build, lead, and develop the country commercial organization, including sales, marketing, and customer-facing roles as the business scales.
Establish commercial processes, governance, and ways of working as part of the country build-out.
Foster a culture of accountability, collaboration, and performance excellence.
Contribute to regional and country-specific initiatives.
Travel nationally and internationally.
Required Skills, Experience and Education:
Advanced degree required (e.g., MSc, PhD, MD, PharmD).
10+ years of experience in pharmaceutical or biotech commercial roles.
Significant experience in oncology commercial leadership at country level.
Proven track record of successful oncology product launches in Italy and successful HCP / KOL interactions.
Proven project management experience.
Excellent communication skills, both in person and virtual.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly preferred.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, Commercial, France is responsible for defining and executing the local commercial strategy for oncology products. This role is accountable for building the commercial organization, driving launch and growth performance, and ensuring strong alignment across Medical Affairs, Market Access, and other key functions.
The incumbent needs to proactively recognize and address relevant systemic (e.g. health care structures, competitors, data gaps, diagnostic challenges, missing advocacy) and HCP related opportunities (e.g. therapeutic gaps, differentiation, economical attributes, clear messaging of patient- and physician relevant benefits). The Senior Director Commercial will further oversee the generation of insights from the therapeutic field, and translate these insights into a comprehensive, cross-functional strategy. Supporting a clear positioning and aligned communication approach, the incumbent will in addition secure the development and implementation of tactics and tools for the field force to effectively address customer needs.
Responsibilities:
Act as the Commercial Lead for France accountable for local commercial strategy, execution, and performance across the oncology portfolio.
Serve as a core member of the France Leadership Team, contributing France strategy, launch planning, and business decisions.
Partner with regional and local Medical Affairs and Marketing Team to translate clinical and economic evidence into compelling value communications tailored for France stakeholders including HCPs and payers.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements.
Translate regional commercial strategy into locally optimized plans aligned with market dynamics, customer needs, and healthcare system requirements in close collaboration with the ED Marketing, Europe.
Collaborate with regional commercial teams by representing the country and contributing to commercial plans shaping our strategy.
Develop and execute country-level brand and portfolio strategies across pre-launch, launch, and post-launch phases.
Drive demand generation and appropriate use through non-promotional and promotional channels in compliance with local regulations.
Lead forecasting, budgeting, and operational planning for the country in close collaboration with the ED, Commercial Excellence, Business Analytics and Insights, Europe.
Lead commercial launch readiness for oncology products, including customer strategy, segmentation, targeting, and field force planning.
Partner closely with Medical Affairs and Market Access to ensure integrated launch execution and consistent external engagement.
Monitor performance, competitive dynamics, and market trends, adjusting strategy as needed.
Oversee customer engagement strategy across key stakeholders, including oncologists, treatment centers, and healthcare organizations.
Ensure effective field force deployment and capability building (e.g., sales, key account management, customer-facing roles).
Work closely with Medical Affairs, Market Access, Regulatory, Finance, Corporate Affairs and other support functions to ensure aligned and compliant country execution.
Ensure strong integration of commercial plans with access, medical, and evidence strategies.
Build, lead, and develop the country commercial organization, including sales, marketing, and customer-facing roles as the business scales.
Establish commercial processes, governance, and ways of working as part of the country build-out.
Foster a culture of accountability, collaboration, and performance excellence.
Contribute to regional and country-specific initiatives.
Travel nationally and internationally.
Required Skills, Experience and Education:
Advanced degree required (e.g., MSc, PhD, MD, PharmD).
10+ years of experience in pharmaceutical or biotech commercial roles.
Significant experience in oncology commercial leadership at country level.
Proven track record of successful oncology product launches in France and successful HCP / KOL interactions.
Proven project management experience.
Excellent communication skills, both in person and virtual.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly preferred.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting to the VP, GM, Midsized Markets, the Senior Director, Medical Affairs, Midsize Markets Europe, is the medical leader responsible for defining and executing the medical strategy for oncology products in our portfolio within Midsized markets. This role serves as the medical voice within the Midsized markets Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs. This leader will ensure that Midsized markets medical considerations are embedded in the regional medical strategy and plans and will partner with the Midsized markets country managers and crossfunctional teams, as well as VP Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the Midsized markets medical team and working closely with the Global, Regional, Country Medical Affairs teams across Med Affairs functions.
Responsibilities:
Act as the Medical lead for Midsized Markets, accountable for medical strategy, execution, and impact across the RevMed portfolio.
Serve as a core member of the Midsized Markets Leadership Team, contributing insights to medical and clinical development strategy, launch planning, and business decisions.
Establish Midsized markets medical strategy across pre-launch, launch, and post-launch phases.
Oversee all aspects of medical strategy and execution in Midsized markets.
Cross-functionally align efforts seamlessly with access, regulatory, and commercial objectives while building and executing upon the medical plan.
Collaborate effectively with regional and global teams by contributing to overall medical strategy, strongly partnering with local, regional and global clinical development and operations teams.
Translate global medical and clinical strategies into relevant medical strategy.
Represent the company as the senior medical expert within the local oncology and scientific community, acting as a spokesperson for Midsized markets.
Gather, analyze and interpret clinical data, providing strategic insights to inform critical decisions.
Build strong relationships with national key opinion leaders, oncology networks, academic institutions, and scientific societies.
Lead scientific exchange, advisory boards, investigator and other external meetings, press conferences, and congress engagement at country level.
Provide medical leadership on evidence generation activities including local studies, real-world evidence initiatives, and investigator-initiated research (where permitted).
Ensure effective execution of publication plans and scientific communication activities.
Lead medical launch readiness for oncology products, including training, scientific materials, and field medical engagement plans.
Partner with Market Access and Commercial country and regional teams to support value communication and reimbursement-related interactions from a medical perspective, e.g. representing and defining evidence and value of innovation at oral HTA hearings.
Support lifecycle management activities including new indications, label updates, and competitive positioning.
Provide medical review and approval of non-promotional materials in accordance with local regulations and company policies.
Help recruit country Medical teams, including Medical Directors and Medical Science Liaisons.
Establish medical processes, governance, and ways of working as part of the Midsized markets build-out.
Foster a culture of scientific rigor, compliance, and collaboration.
Ensure all medical activities comply with local regulations, national and EFPIA codes, and internal company policies.
Represent Midsized markets Medical Affairs in company governance and risk management forums.
Required Skills, Experience and Education:
Advanced degree required (MD or PhD).
Strong background and experience in oncology required.
10+ years’ experience in Medical Affairs with a track record of country leadership.
Experience with scientific data generation, clinical trial interpretation, and communication of complex data to diverse audiences.
Proven value and benefit assessment experience, with deep understanding of midsized markets access, local healthcare systems and regulatory landscape.
Strong stakeholder management and ability to collaborate with internal and external partners.
Proven experience supporting oncology product launches in a European market.
Experience in biotech.
Excellent communication skills, both in person and virtual.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial environment.
Demonstrated strong leadership presence.
Has demonstrated adaptability and flexibility.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environment.
Highly organized and motivated individual possessing excellent communication, presentation and interpersonal skills. Thrives in a fast-paced, dynamic small company environment and able to adjust priorities and workload based upon changing needs.
Willingness to travel nationally and internationally.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-LO1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting to the Vice President, General Manager, Mid-Sized Markets of Europe, the Country Manager, Switzerland will lead the expansion efforts critical to maximizing the opportunity for Revolution Medicines (RevMed) innovation to help patients. In collaboration with the regional leadership team, the successful catalytic leader will develop and execute commercial and operational strategy to accelerate the engagement with key stakeholders and customers (government authorities, regulatory authorities, payer authorities, KOLs) in Switzerland as well as all necessary constituencies to support expansion into the European region - ensuring that reimbursement and access considerations are integrated in the existing and future clinical program design of the company portfolio / pipeline. The incumbent will be responsible for developing pre-launch and commercialization strategic plans for Switzerland and providing Swiss-specific input into lifecycle plans across the RevMed portfolio. This individual will have full accountability for the Switzerland P&L, all Switzerland operations and will ensure official, fiduciary, corporate, legal and compliance requirements are met locally and for the European region respectively.
Responsibilities:
Develop and execute comprehensive plans for the company’s expansion in Switzerland.
Develop and manage the Switzerland P&L including the budget for operations, ensuring optimal resource allocation.
As dictated by the commercialization strategy, build and lead the required multifunctional management team, working with corporate functional leaders to ensure that each team member and business function execute against the clear and well-aligned business objectives.
Lead the planning and execution of product launches in Switzerland, including PEL, market access strategies, pricing, medical affairs atrategy, disease area and marketing strategy, and where appropriate, early access programs.
Lead the Swiss Government/Corporate Affairs efforts ensuring the successful execution of global and European strategies, advocating for policies that promote patient access. Cultivate and maintain strategic relationships with government entities, patient organizations, healthcare providers, industry associations, and medical societies through innovative engagement programs.
Represent the company in Swiss healthcare policy forums and industry associations, collaborate with peers to shape collective positions and advocate for patient centered policies.
Evaluate the competitive environment and understand the profile of portfolio compounds and the patients to serve to identify opportunities and challenges in the oncology market across Europe and other key markets.
Set key launch and financial performance metrics including revenue, profitability etc.
Provide Switzerland input for Mid-Sized Markets, Regional and Global Clinical Development Plans.
Support the Clinical Operations team by ensuring appropriate Swiss site selection, quality and enrollment in-line with regulatory/compliance requirements.
Co-lead with Finance, Legal, and Commercial, the selection and contract negotiation with any local distributor and Trade 3rd parties and upon completion of contract, oversee and be accountable for successful execution and achievement of goals by the distributor.
Support the effective negotiation of consultant/agency contracts for timely and cost-effective services in various business areas to support pre-launch and launch activities.
Foster a culture within the Mid-Sized markets leadership team, regional and global team consistent with the global RevMed values and vision/mission.
Build, lead, and develop the country organization, including medical, access, sales, marketing, and customer-facing roles as the business scales.
Establish commercial processes, governance, and ways of working as part of the country build-out.
Foster a culture of accountability, collaboration, and performance excellence.
Establish country governance, risk management, and compliance framework and SOPs.
Ensure all activities comply with local regulations, industry codes, and internal company policies.
Required Skills, Experience and Education:
Advanced degree in life sciences, business administration, or a related field.
Minimum 15 years of proven experience in leadership roles within the biopharmaceutical industry in the field of oncology.
In-depth knowledge of the Swiss pharmaceutical market, access, pricing and regulatory environment.
Organizational and P&L leadership experience in Switzerland required.
Proven track record shaping and executing country strategy and influencing policy at a senior industry level.
Proven experience building and developing a high performing cross-functional team is a must.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
In depth knowledge of Swissmedic, approval and early access mechanisms of medicinal products in Switzerland.
Fluency in both verbal and written English and German; French and/or Italian is an advantage.
Ability to create and nurture a strong culture of collaboration and authenticity to extend and replicate the RevMed culture.
Proven success in building effective relationships with internal stakeholders, regional authorities, and vendors.
Highly organized and motivated individual possessing excellent communication, presentation and interpersonal skills.
Strong leadership and influencing skills with the ability to create a clear sense of direction.
Thrives in a fast-paced, dynamic small company environment and able to roll out the sleeves to get things done.
Preferred Skills:
Experience with an oncology launch in Switzerland is desired.
Serve as business partners to Development and Clinical Operations functions.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-LO1 #LI-Hybrid
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting to the VP, General Manager, Spain the Senior Director, Medical Affairs, Spain is the medical leader responsible for defining and executing the local medical strategy for oncology products. This role serves as the medical voice within the spanish Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs.
This leader will ensure that Spanish medical considerations are embedded in the regional medical strategy and plans and will partner with the General Manager and crossfunctional teams, as well as the VP, Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the spanish medical team and work closely with the Global and Regional Medical Affairs teams across Med Affairs functions.
Responsibilities:
Act as the Medical Affairs lead for Spain, accountable for local medical strategy, execution, and impact across the oncology portfolio.
Translate global medical and clinical strategies into locally relevant medical plans aligned with Spanish regulations and clinical practice.
Build and maintain strong relationships with national and regional key opinion leaders, oncology networks, academic institutions, and scientific societies.
Lead scientific exchange, advisory boards, investigator and other external meetings, press conferences, and congress engagement at country level.
Serve as medical expert within the local oncology and scientific community, acting as a spokesperson for Spain.
Collaborate effectively with regional and global teams by contributing to overall medical affairs strategy, strongly partnering with local, regional and global clinical development and operations teams.
Drive local medical strategy across pre-launch, launch, and post-launch phases.
Provide local medical expertise on evidence generation activities including local studies, real-world evidence initiatives, and investigator-initiated research (where permitted).
Ensure effective execution of publication plans and scientific communication activities.
Lead medical launch readiness for oncology products, including training, scientific materials, and field medical engagement plans.
Partner with Market Access and Commercial teams to support value communication and reimbursement-related interactions from a medical perspective, e.g. representing and defining evidence and value of innovation at oral HTA hearings.
Support lifecycle management activities including new indications, label updates, and competitive positioning.
Work closely with Market Access, Commercial, Regulatory, Safety, and Corporate Affairs teams to ensure aligned and compliant execution of country plans.
Provide medical review and approval of non-promotional materials in accordance with local regulations and company policies.
Build, lead, and develop the Spanish Medical Affairs team, including Medical Directors and Medical Science Liaisons.
Establish medical processes, governance, and ways of working as part of the Spanish build-out.
Foster a culture of scientific rigor, compliance, and collaboration.
Ensure all medical activities comply with local regulations, national and EFPIA codes, and internal company policies.
Represent Medical Affairs in spanish governance and risk management forums.
Required Skills, Experience and Education:
Advanced degree required (MD, PhD, or PharmD).
Strong background and experience in oncology required.
10+ years’ experience in Medical Affairs with a track record of country leadership.
Proven value and benefit assessment experience, with deep understanding of country payer decision-making.
Strong stakeholder management and ability to collaborate with internal and external partners.
Proven experience supporting oncology product launches in a European market.
Strong understanding of the local healthcare system, clinical practice, and regulatory environment.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly.
Excellent communication skills, both in person and virtual.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial environment.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting to the VP, General Manager, UK the Senior Director, Medical Affairs, UK is the medical leader responsible for defining and executing the local medical strategy for oncology products. This role serves as the medical voice within the UK Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs.
This leader will ensure that UK medical considerations are embedded in the regional medical strategy and plans and will partner with the General Manager and crossfunctional teams, as well as the VP, Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the UK medical team and work closely with the Global and Regional Medical Affairs teams across Med Affairs functions.
Responsibilities:
Act as the Medical Affairs lead for UK, accountable for local medical strategy, execution, and impact across the oncology portfolio.
Translate global medical and clinical strategies into locally relevant medical plans aligned with UK regulations and clinical practice.
Build and maintain strong relationships with national and regional key opinion leaders, oncology networks, academic institutions, and scientific societies.
Lead scientific exchange, advisory boards, investigator and other external meetings, press conferences, and congress engagement at country level.
Serve as medical expert within the local oncology and scientific community, acting as a spokesperson for UK.
Collaborate effectively with regional and global teams by contributing to overall medical affairs strategy, strongly partnering with local, regional and global clinical development and operations teams.
Drive local medical strategy across pre-launch, launch, and post-launch phases.
Provide local medical expertise on evidence generation activities including local studies, real-world evidence initiatives, and investigator-initiated research (where permitted).
Ensure effective execution of publication plans and scientific communication activities.
Lead medical launch readiness for oncology products, including training, scientific materials, and field medical engagement plans.
Partner with Market Access and Commercial teams to support value communication and reimbursement-related interactions from a medical perspective, e.g. representing and defining evidence and value of innovation at oral HTA hearings.
Support lifecycle management activities including new indications, label updates, and competitive positioning.
Work closely with Market Access, Commercial, Regulatory, Safety, and Corporate Affairs teams to ensure aligned and compliant execution of country plans.
Provide medical review and approval of non-promotional materials in accordance with local regulations and company policies.
Build, lead, and develop the UK Medical Affairs team, including Medical Directors and Medical Science Liaisons.
Establish medical processes, governance, and ways of working as part of the UK build-out.
Foster a culture of scientific rigor, compliance, and collaboration.
Ensure all medical activities comply with local regulations, national and EFPIA codes, and internal company policies.
Represent Medical Affairs in UK governance and risk management forums.
Required Skills, Experience and Education:
Advanced degree required (MD, PhD, or PharmD).
Strong background and experience in oncology required.
10+ years’ experience in Medical Affairs with a track record of country leadership.
Proven value and benefit assessment experience, with deep understanding of country payer decision-making.
Strong stakeholder management and ability to collaborate with internal and external partners.
Proven experience supporting oncology product launches in a European market.
Strong understanding of the local healthcare system, clinical practice, and regulatory environment.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly.
Excellent communication skills, both in person and virtual.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial environment.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Willingness to travel nationally and internationally.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
General Purpose
The Senior Director, Head Pharmacist/Responsible Pharmacist guarantees the pharmaceutical responsibility of the laboratory as “exploitant” (see definition of the “exploitant”, Article R.5124-2, 3 ° of the French Public Health Code) and assumes the role of "Responsible Pharmacist" as described in Article R.5124-36 of the Public Health Code. Responsibilities include:
Organize and supervise all pharmaceutical operations of the company or organization, including manufacturing, advertising, information, pharmacovigilance, batch monitoring and withdrawal, distribution, import and export of the drugs, products, objects or articles concerned, as well as the corresponding storage operations.
Ensure that transport conditions guarantee the proper preservation, integrity and safety of these medicines, products, objects or articles.
Acknowledge the files related to marketing authorization applications submitted by Corporate or organization and any other application related to the activities they organize and supervise.
Participate in the development of research and study programs.
Imperson authority over delegate and deputy pharmacists; approve their hiring and be consulted on their dismissal, except in the case of an army pharmacist-chemist.
Appoint interim delegate pharmacists.
Inform the other directors of the company or organization of any obstacle or limitation to the exercise of these powers.
Implement all necessary means to comply with the obligations set out in articles R. 5124-48 and R. 5124-48-1;
In the case of medicinal products intended to be marketed in the territory, he(she) ensures that the safety measures referred to in article R. 5121-138-1 have been affixed to the packaging in accordance with the conditions set out in articles R. 5121-138-1 to R. 5121-138-4;
Notify the Agence nationale de sécurité du médicament et des produits de santé (ANSM : French National Agency for the Safety of Medicines and Health Products) of any launching on the national market of a medicinal product which is considered to be falsified within the provisions of article L. 5111-3, and for which they are responsible for the manufacture, exploitation and distribution.
They organize the quality system within the laboratory in accordance with French laws and regulations (good distribution practices, good pharmacovigilance practices, good manufacturing practices) and laboratory requirements.
They also support the transversal activities carried out by the marketing, medical, compliance and market access departments.
The Senior Director, Head Pharmacist/Responsible Pharmacist, France takes part in the deliberations of the management, administrative, executive or supervisory bodies, or those of any other body with an executive function, of the company or organization, when these deliberations concern or may affect the performance of the tasks falling under his/her responsibility as described above.
The RP is responsible for ensuring compliance with professional ethics and all regulations issued in the interests of public health. He/she must also ensure that the responsibilities of pharmacists and staff under his/her authority are clearly defined.
In accordance with articles L. 5121-14-3, R. 5121-152 and L. 5121-164 of the French Public Health Code, the RP ensures that pharmacovigilance cases are reviewed and processed within the appropriate timeframes.
In accordance with article L5121-9-2 of the French Public Health Code, the RP immediately informs the French National Agency for the Safety of Medicines and Health Products of any prohibition or restriction imposed by the competent authority of any country in which the medicinal product for human use is marketed, and of any other new information likely to influence the evaluation of the benefits and risks of the medicinal product for human use or the product concerned.
In addition, the Responsible Pharmacist also has knowledge of :
the role of professional bodies and organizations that regulate those who supply medical products to the public.
the ANSM's role in handling controlled drugs.
the role of the European Medicines Agency (EMA) and the use of EUDRAGMDP.
the Directive on Falsified Medicines.
the principles and guidelines of good manufacturing practice, and how GMP/GDP principles maintain product quality throughout the distribution chain.
Responsibilities
In the performance of the duties, the Employee is responsible for the following tasks in French territory:
Regulatory Affairs:
Submission and obtaining the opening authorization application for the “Exploitant” pharmaceutical establishment.
Filling and submission of the annual facility master file (once a year).
Relationships with the Health competent authority – the French Agency for the Safety of Medicines and Health Products (ANSM).
Participation in the management of early access programs.
Monitoring of drug marketing (declaration to the health authority of the date of initial marketing, reporting of prohibition or restriction decisions or any information likely to influence the benefit/risk assessment).
Validation of the Advertising and Medical Information process.
Participation in pharmaceutical document archiving management.
Implementation of the Regulatory Intelligence process.
Supervision of pharmaceutical contracts (head office and outsourced activities).
Quality Assurance/Supply Chain:
Regular audits of internal pharmaceutical activities (distribution, medical information, promotion processes, claims, pharmacovigilance processes, etc.).
Implementation of a risk management approach (document management, claims, audits, continuous improvement, premises, suppliers, shortages, etc.) and business continuity plan.
Implementation of change control management process following regulatory approvals (marketing authorization, variations, risk management plan, etc.).
Participation in audits and inspections by authorities (ANSM, etc.).
Follow-up of batch release for distribution in France and tracking/traceability.
Management of batch recalls with the marketing authorization holder, the health authority and distribution stakeholders.
Management of shortages with the health authority.
Storage and distribution management.
Management of quality complaints.
Implementation of procedures (SOP).
Implementation of compliance with the French Charter of Promotional Information and its Guidance.
Implementing quality compliance:
Planning, execution and follow-up of audits.
Implementation of KPIs (definition, collection and analysis of KPIs for key pharmaceutical activities).
Pharmacovigilance and drug safety management:
Implementation of the local pharmacovigilance process.
Nomination of local Qualified Persons responsible for Pharmacovigilance.
Interaction with European Qualified Person responsible for Pharmacovigilance (QPPV); Global Patient Safety Department (GPS)and PV database.
Procedures and data management.
Report to Competent authorities.
Collection, registration, assessment, report and follow-up of adverse events.
Screening of local scientific and medical literature for pharmacovigilance relevant information.
Local Signal detection.
Review and validation of Periodic Safety Update Report (PSUR).
Reconciliation of shared PV data.
Implementation of key performance indicators (KPI).
Monitoring of product good use and off-label use, and declaration to competent authorities if applicable.
Medical information management:
Implementation of medical information process in collaboration with the Medical information department (data management, standard responses, access to literature database).
Collection, registration and response to medical information requests.
Reconciliation of shared medical information data.
Implementation of KPI.
Advertising and promotional information:
Promotional and non-promotional material review and approval.
Review and submission to Health authority of promotional material.
Approval and dissemination of the positive list.
Logistical management of material with traceability (withdrawal, archiving, etc.).
Personnel training:
Implementation of a local training process for pharmaceutical and compliance processes.
Review and validation of training material for commercial and medical teams.
Validation of integration and ongoing staff training plans, and monitoring of training plans.
Ensuring that all staff are trained in Good Practices, their own tasks, product identification, risks of drug falsification and specific training for products requiring more rigorous handling.
Competency assessment and empowerment of key personnel.
Participation to Compliance management:
Participation to implementation of French law about anti-bribery, transparency and compliance of interaction with HCPs and HCOs.
Participation to legal review of agreements with healthcare professionals, hospitals, organizations, etc.
Management of the Pharmaceutical Affairs Department in France
Team leadership, development and management;
Recruitment, training and development of team members;
Follow-up of team objectives.
The above list of tasks is not exhaustive.
Required Skills, Experience and Education:
Doctor in pharmacy and able to be registered as Responsible Pharmacist.
Specialization in regulatory affairs and quality.
Minimum 15 years of proven experience in leadership roles within the biopharmaceutical industry in the field of oncology.
Fluency in both verbal and written French and English.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Proven track record shaping and executing country strategy and influencing policy at a senior industry level.
In-depth knowledge of the French pharmaceutical market and regulatory environment.
Ability to create and nurture a strong culture of collaboration and authenticity to extend and replicate the RevMed culture.
Proven success in building effective relationships with internal stakeholders, regional authorities, and vendors.
Highly organized and motivated individual possessing excellent communication, presentation and interpersonal skills.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-LO1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting to the VP, General Manager, France the Senior Director, Medical Affairs, France is the medical leader responsible for defining and executing the local medical strategy for oncology products. This role serves as the medical voice within the French Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs.
This leader will ensure that French medical considerations are embedded in the regional medical strategy and plans and will partner with the General Manager and crossfunctional teams, as well as the VP, Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the French medical team and work closely with the Global and Regional Medical Affairs teams across Med Affairs functions.
Responsibilities:
Act as the Medical Affairs lead for France, accountable for local medical strategy, execution, and impact across the oncology portfolio.
Translate global medical and clinical strategies into locally relevant medical plans aligned with French regulations and clinical practice.
Build and maintain strong relationships with national and regional key opinion leaders, oncology networks, academic institutions, and scientific societies.
Lead scientific exchange, advisory boards, investigator and other external meetings, press conferences, and congress engagement at country level.
Serve as medical expert within the local oncology and scientific community, acting as a spokesperson for France.
Collaborate effectively with regional and global teams by contributing to overall medical affairs strategy, strongly partnering with local, regional and global clinical development and operations teams.
Drive local medical strategy across pre-launch, launch, and post-launch phases.
Provide local medical expertise on evidence generation activities including local studies, real-world evidence initiatives, and investigator-initiated research (where permitted).
Ensure effective execution of publication plans and scientific communication activities.
Lead medical launch readiness for oncology products, including training, scientific materials, and field medical engagement plans.
Partner with Market Access and Commercial teams to support value communication and reimbursement-related interactions from a medical perspective, e.g. representing and defining evidence and value of innovation at oral HTA hearings.
Support lifecycle management activities including new indications, label updates, and competitive positioning.
Work closely with Market Access, Commercial, Regulatory, Safety, and Corporate Affairs teams to ensure aligned and compliant execution of country plans.
Provide medical review and approval of non-promotional materials in accordance with local regulations and company policies.
Build, lead, and develop the French Medical Affairs team, including Medical Directors and Medical Science Liaisons.
Establish medical processes, governance, and ways of working as part of the french build-out.
Foster a culture of scientific rigor, compliance, and collaboration.
Ensure all medical activities comply with local regulations, national and EFPIA codes, and internal company policies.
Represent Medical Affairs in french governance and risk management forums.
Required Skills, Experience and Education:
Advanced degree required (MD, PhD, or PharmD).
Strong background and experience in oncology required.
10+ years’ experience in Medical Affairs with a track record of country leadership.
Proven value and benefit assessment experience, with deep understanding of country payer decision-making.
Strong stakeholder management and ability to collaborate with internal and external partners.
Proven experience supporting oncology product launches in a European market.
Strong understanding of the local healthcare system, clinical practice, and regulatory environment.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly.
Excellent communication skills, both in person and virtual.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial environment.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, Market Access is responsible for defining and executing the country market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. This role shapes reimbursement and access strategy, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities.
This position will partner with commercial and medical affairs teams to deliver launch activities by providing access insights, developing evidence-based HTA, Pricing & Reimbursement dossiers and tools, engaging with market access and public affairs stakeholders as well as driving pricing strategy activities, and lead the activities to deliver access results supporting the overall success of the product launches.
Responsibilities:
Lead Market Access & Reimbursement: Develop and implement strategies to support access and pricing decisions for oncology products within the France healthcare system.
HTA & Pricing Filings: Lead preparation and submission of value dossiers, benefit assessments (e.g., AMNOG/G-BA, HAS, AIFA…) and pricing negotiations with statutory health insurance decision makers (e.g., GKV-SV, CEPS…).
Partner with regional and local Medical Affairs and Marketing team to translate clinical and economic evidence into compelling value communications tailored for french payers.
Build and maintain strong relationships with key external stakeholders (payers, HTA authorities, policy influencers). Representation of Revolution Medicines at local trade associations for market access subjects.
Work with regional EU Market Access teams to align local access strategy with broader European and corporate objectives, especially in terms of aligning the European regulatory and JCA strategy and execution with local value dossier submission and pricing negotiation strategy. Provide early market access input to regional and EU clinical development and medical teams.
Lead negotiation with all levels of national payers.
Develop innovative pricing and value based contracting models to optimize the acceleration of reimbursement approvals.
Policy Monitoring: Monitor health policy developments, HTA processes and local reimbursement environments to inform strategy.
Represent Market Access in Country Leadership Team meetings and contribute to overall business strategy.
Drive access and value related projects such as landscape assessments, payer market research, payer advisory boards and general guidance on local strategies.
Development of outreach and engagement plan for key payers creating and maintaining a strong network.
Create and lead a market access team, including coaching, performance management, and talent development when a team is in place.
Early access planning of new products and indications, drive launch readiness for multiple oncology assets (portfolio responsibility).
Influence EU / regional access strategy based on local payer insights from a leadership position
Travel nationally and internationally.
Required Skills, Experience and Education:
Advanced degree (e.g., Life Sciences, Pharmacy, Health Economics, Public Health).
A minimum of 10 years’ experience in market access, pricing, reimbursement or health economics (Pharma/Biotech).
Proven value and benefit assessment experience, with deep understanding of country payer decision-making.
Demonstrated success and experience supporting oncology product pre-launch, launch and post launch in France.
Demonstrated success in negotiating pricing and reimbursement conditions with public administrations and health authorities.
Strong stakeholder management and ability to collaborate with internal and external partners.
Excellent interpersonal and communication skills.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Experience in a biotech and/or in a build-out or first-in-country role strongly preferred.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting directly to the Sr. Director, Global Analytics and Insights, the Director, Global Forecasting role requires strategic thinking and expertise to provide critical contributions to disease area strategy, life-cycle planning and product and portfolio decisions. This role involves developing, refining, and communicating key strategic and revenue forecast assumptions and analyses to inform and support decision-making across the organization. This role will also work directly with Regional Forecasting leads to ensure consistency in forecast approach, assumptions, and analyses. The ideal candidate will have experience working on pipeline molecules in Oncology, strong problem-solving skills, a strategic mindset, and will exhibit curiosity, flexibility, and be comfortable with ambiguity.
This position would ideally be based at our headquarters in Redwood City, CA., however open to remote candidates who are willing to travel to our CA office on a regular basis.
Responsibilities include:
Develops and maintains long-term forecast models and scenario plans for RevMed’s products across indications.
Provides portfolio level views and analyses to support organizational decision making via streamline models and consolidation processes.
Communicates and aligns key internal stakeholders around key forecast assumptions.
Understands complex markets, disease states, competitive landscapes, and relevant market and managed care dynamics and uses this knowledge to develop strategic forecasts and plans.
Synthesizes and communicates the similarities, differences, and considerations necessary to inform Global clinical development plans.
Exhibits analytical rigor in the valuation of business opportunities and the quantification of risk.
Participates in cross-functional teams to gather input for functional activities, and ensure alignment.
Partners closely with other Insights and Analytics functions (Market Research, Data Analytics, Competitive Intelligence) to inform the forecast.
Works closely with Pipeline Marketing, Clinical Development, Portfolio Management, and Medical Affairs to support early-stage decision making.
Works closely with Regional forecasting leads to ensure consistency and understand differences in forecasts.
Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future.
Collaborates with vendor partners to manage various deliverables and analyses.
Required Skills, Experience and Education:
Bachelor's degree required (MBA preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a related analytics/forecasting role.
Experience developing long-range patient-based forecasts for oncology products.
Experience supporting pipeline and portfolio decision making and supporting executional strategy for pipeline analytics and insights.
Track record of being a collaborative team player, and adaptive to meet the needs of a growing business.
Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships.
Demonstrated ability to influence senior management and key business partners.
Proven experience in a smaller, rapidly growing, company.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.
Preferred Skills:
8+ years of experience in patient-based forecasting with focus in Oncology.
Experience with targeted oncolytics.
Experience working with Global teams.
Demonstrated ability to synthesize complex information and influence decision-making at the executive level.
#LI-Remote #LI-JW1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting to the VP, General Manager, Italy the Senior Director, Medical Affairs, Italy is the medical leader responsible for defining and executing the local medical strategy for oncology products. This role serves as the medical voice within the Italian Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs.
This leader will ensure that Italian medical considerations are embedded in the regional medical strategy and plans and will partner with the General Manager and crossfunctional teams, as well as the VP, Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the Italian medical team and work closely with the Global and Regional Medical Affairs teams across Med Affairs functions.
Responsibilities:
Act as the Medical Affairs lead for Italy, accountable for local medical strategy, execution, and impact across the oncology portfolio.
Translate global medical and clinical strategies into locally relevant medical plans aligned with Italian regulations and clinical practice.
Build and maintain strong relationships with national and regional key opinion leaders, oncology networks, academic institutions, and scientific societies.
Lead scientific exchange, advisory boards, investigator and other external meetings, press conferences, and congress engagement at country level.
Serve as medical expert within the local oncology and scientific community, acting as a spokesperson for Italy.
Collaborate effectively with regional and global teams by contributing to overall medical affairs strategy, strongly partnering with local, regional and global clinical development and operations teams.
Drive local medical strategy across pre-launch, launch, and post-launch phases.
Provide local medical expertise on evidence generation activities including local studies, real-world evidence initiatives, and investigator-initiated research (where permitted).
Ensure effective execution of publication plans and scientific communication activities.
Lead medical launch readiness for oncology products, including training, scientific materials, and field medical engagement plans.
Partner with Market Access and Commercial teams to support value communication and reimbursement-related interactions from a medical perspective, e.g. representing and defining evidence and value of innovation at oral HTA hearings.
Support lifecycle management activities including new indications, label updates, and competitive positioning.
Work closely with Market Access, Commercial, Regulatory, Safety, and Corporate Affairs teams to ensure aligned and compliant execution of country plans.
Provide medical review and approval of non-promotional materials in accordance with local regulations and company policies.
Build, lead, and develop the Italian Medical Affairs team, including Medical Directors and Medical Science Liaisons.
Establish medical processes, governance, and ways of working as part of the Italian build-out.
Foster a culture of scientific rigor, compliance, and collaboration.
Ensure all medical activities comply with local regulations, national and EFPIA codes, and internal company policies.
Represent Medical Affairs in Italian governance and risk management forums.
Required Skills, Experience and Education:
Advanced degree required (MD, PhD, or PharmD).
Strong background and experience in oncology required.
10+ years’ experience in Medical Affairs with a track record of country leadership.
Proven value and benefit assessment experience, with deep understanding of country payer decision-making.
Strong stakeholder management and ability to collaborate with internal and external partners.
Proven experience supporting oncology product launches in a European market.
Strong understanding of the local healthcare system, clinical practice, and regulatory environment.
Experience in a US-based or global biotech and/or in a build-out or first-in-country role strongly.
Excellent communication skills, both in person and virtual.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial environment.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Willingness to travel nationally and internationally.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, Market Access is responsible for defining and executing the country market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. This role shapes reimbursement and access strategy, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities.
This position will partner with commercial and medical affairs teams to deliver launch activities by providing access insights, developing evidence-based HTA, Pricing & Reimbursement dossiers and tools, engaging with market access and public affairs stakeholders as well as driving pricing strategy activities, and lead the activities to deliver access results supporting the overall success of the product launches.
Responsibilities:
Lead Market Access & Reimbursement: Develop and implement strategies to support access and pricing decisions for oncology products within the UK healthcare system.
HTA & Pricing Filings: Lead preparation and submission of value dossiers, benefit assessments (e.g., AMNOG/G-BA, HAS, AIFA…) and pricing negotiations with statutory health insurance decision makers (e.g., GKV-SV, CEPS…).
Partner with regional and local Medical Affairs and Marketing team to translate clinical and economic evidence into compelling value communications tailored for UK payers.
Build and maintain strong relationships with key external stakeholders (payers, HTA authorities, policy influencers). Representation of Revolution Medicines at local trade associations for market access subjects.
Work with regional EU Market Access teams to align local access strategy with broader European and corporate objectives, especially in terms of aligning the European regulatory and JCA strategy and execution with local value dossier submission and pricing negotiation strategy. Provide early market access input to regional and EU clinical development and medical teams.
Lead negotiation with all levels of national payers.
Develop innovative pricing and value based contracting models to optimize the acceleration of reimbursement approvals.
Policy Monitoring: Monitor health policy developments, HTA processes and local reimbursement environments to inform strategy.
Represent Market Access in Country Leadership Team meetings and contribute to overall business strategy.
Drive access and value related projects such as landscape assessments, payer market research, payer advisory boards and general guidance on local strategies.
Development of outreach and engagement plan for key payers creating and maintaining a strong network.
Create and lead a market access team, including coaching, performance management, and talent development when a team is in place.
Early access planning of new products and indications, drive launch readiness for multiple oncology assets (portfolio responsibility).
Influence EU / regional access strategy based on local payer insights from a leadership position
Travel nationally and internationally.
Required Skills, Experience and Education:
Advanced degree (e.g., Life Sciences, Pharmacy, Health Economics, Public Health).
A minimum of 10 years’ experience in market access, pricing, reimbursement or health economics (Pharma/Biotech).
Proven value and benefit assessment experience, with deep understanding of country payer decision-making.
Demonstrated success and experience supporting oncology product pre-launch, launch and post launch in UK.
Demonstrated success in negotiating pricing and reimbursement conditions with public administrations and health authorities.
Strong stakeholder management and ability to collaborate with internal and external partners.
Excellent interpersonal and communication skills.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Experience in a biotech and/or in a build-out or first-in-country role strongly preferred.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, Market Access is responsible for defining and executing the country market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. This role shapes reimbursement and access strategy, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities.
This position will partner with commercial and medical affairs teams to deliver launch activities by providing access insights, developing evidence-based HTA, Pricing & Reimbursement dossiers and tools, engaging with market access and public affairs stakeholders as well as driving pricing strategy activities, and lead the activities to deliver access results supporting the overall success of the product launches.
Responsibilities:
Lead Market Access & Reimbursement: Develop and implement strategies to support access and pricing decisions for oncology products within the Italian healthcare system.
HTA & Pricing Filings: Lead preparation and submission of value dossiers, benefit assessments (e.g., AMNOG/G-BA, HAS, AIFA…) and pricing negotiations with statutory health insurance decision makers (e.g., GKV-SV, CEPS…).
Partner with regional and local Medical Affairs and Marketing team to translate clinical and economic evidence into compelling value communications tailored for Italian payers.
Build and maintain strong relationships with key external stakeholders (payers, HTA authorities, policy influencers). Representation of Revolution Medicines at local trade associations for market access subjects.
Work with regional EU Market Access teams to align local access strategy with broader European and corporate objectives, especially in terms of aligning the European regulatory and JCA strategy and execution with local value dossier submission and pricing negotiation strategy. Provide early market access input to regional and EU clinical development and medical teams.
Lead negotiation with all levels of national payers.
Develop innovative pricing and value based contracting models to optimize the acceleration of reimbursement approvals.
Policy Monitoring: Monitor health policy developments, HTA processes and local reimbursement environments to inform strategy.
Represent Market Access in Country Leadership Team meetings and contribute to overall business strategy.
Drive access and value related projects such as landscape assessments, payer market research, payer advisory boards and general guidance on local strategies.
Development of outreach and engagement plan for key payers creating and maintaining a strong network.
Create and lead a market access team, including coaching, performance management, and talent development when a team is in place.
Early access planning of new products and indications, drive launch readiness for multiple oncology assets (portfolio responsibility).
Influence EU / regional access strategy based on local payer insights from a leadership position
Travel nationally and internationally.
Required Skills, Experience and Education:
Advanced degree (e.g., Life Sciences, Pharmacy, Health Economics, Public Health).
A minimum of 10 years’ experience in market access, pricing, reimbursement or health economics (Pharma/Biotech).
Proven value and benefit assessment experience, with deep understanding of country payer decision-making.
Demonstrated success and experience supporting oncology product pre-launch, launch and post launch in Italy.
Demonstrated success in negotiating pricing and reimbursement conditions with public administrations and health authorities.
Strong stakeholder management and ability to collaborate with internal and external partners.
Excellent interpersonal and communication skills.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Experience in a biotech and/or in a build-out or first-in-country role strongly preferred.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, Market Access is responsible for defining and executing the country market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. This role shapes reimbursement and access strategy, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities.
This position will partner with commercial and medical affairs teams to deliver launch activities by providing access insights, developing evidence-based HTA, Pricing & Reimbursement dossiers and tools, engaging with market access and public affairs stakeholders as well as driving pricing strategy activities, and lead the activities to deliver access results supporting the overall success of the product launches.
Responsibilities:
Lead Market Access & Reimbursement: Develop and implement strategies to support access and pricing decisions for oncology products within the Spain healthcare system.
HTA & Pricing Filings: Lead preparation and submission of value dossiers, benefit assessments (e.g., AMNOG/G-BA, HAS, AIFA…) and pricing negotiations with statutory health insurance decision makers (e.g., GKV-SV, CEPS…).
Partner with regional and local Medical Affairs and Marketing team to translate clinical and economic evidence into compelling value communications tailored for Spanish payers.
Build and maintain strong relationships with key external stakeholders (payers, HTA authorities, policy influencers). Representation of Revolution Medicines at local trade associations for market access subjects.
Work with regional EU Market Access teams to align local access strategy with broader European and corporate objectives, especially in terms of aligning the European regulatory and JCA strategy and execution with local value dossier submission and pricing negotiation strategy. Provide early market access input to regional and EU clinical development and medical teams.
Lead negotiation with all levels of national payers.
Develop innovative pricing and value based contracting models to optimize the acceleration of reimbursement approvals.
Policy Monitoring: Monitor health policy developments, HTA processes and local reimbursement environments to inform strategy.
Represent Market Access in Country Leadership Team meetings and contribute to overall business strategy.
Drive access and value related projects such as landscape assessments, payer market research, payer advisory boards and general guidance on local strategies.
Development of outreach and engagement plan for key payers creating and maintaining a strong network.
Create and lead a market access team, including coaching, performance management, and talent development when a team is in place.
Early access planning of new products and indications, drive launch readiness for multiple oncology assets (portfolio responsibility).
Influence EU / regional access strategy based on local payer insights from a leadership position
Travel nationally and internationally.
Required Skills, Experience and Education:
Advanced degree (e.g., Life Sciences, Pharmacy, Health Economics, Public Health).
A minimum of 10 years’ experience in market access, pricing, reimbursement or health economics (Pharma/Biotech).
Proven value and benefit assessment experience, with deep understanding of country payer decision-making.
Demonstrated success and experience supporting oncology product pre-launch, launch and post launch in Spain.
Demonstrated success in negotiating pricing and reimbursement conditions with public administrations and health authorities.
Strong stakeholder management and ability to collaborate with internal and external partners.
Excellent interpersonal and communication skills.
Scientific and solution-orientated mindset and capability to move and execute in a rapidly changing, ambiguous environment.
Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.
Experience in a biotech and/or in a build-out or first-in-country role strongly preferred.
Proven leadership and people management capabilities; demonstrated success in small but fast growing, entrepreneurial commercial environment.
High capacity of social competence for teamwork, coaching and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Remote #LI-MP1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting directly to the Senior Director, Global Insights, the Associate Director, Global Insights role requires strong strategic and analytical capabilities to support disease area strategy, life-cycle planning, and product and portfolio decisions. The individual in this role will be responsible for conducting market research in a variety of geographies to help support the development and potential commercialization of the RevMed portfolio and will be a key contributor to asset strategy, providing data driven insights and recommendations. The ideal candidate will have experience working on pipeline molecules in Oncology across multiple geographies, strong problem-solving skills, a strategic mindset, and will exhibit curiosity, flexibility, and be comfortable with ambiguity.
This position would ideally be based at our headquarters in Redwood City, CA., however open to remote candidates who are willing to travel to our CA office on a regular basis.
Responsibilities include:
Works cross functionally to contribute to and execute the global insights roadmap in support of current business needs and future opportunities across the portfolio of targeted oncology molecules.
Translates insights into clear data-driven recommendations to inform global business decision making.
Communicates insights from market research to drive critical business decisions and strategy.
Leads or supports activities that enhance organizational knowledge regarding the relevant market and potential product attributes, usage, market dynamics, and competition.
Communicates and aligns key internal stakeholders around market research and analytics objectives and outputs including qualifying the results based on the strength of the data and identifying limitations.
Develops and presents actionable recommendations to key stakeholders, focusing on key findings and relevant implications to each stakeholder group, cross functional teams and as appropriate, senior leadership.
Researches, analyzes, and formulates insights on complex markets, various disease states, competitive landscapes, and relevant market and managed care dynamics.
Synthesizes and communicates the similarities, differences, and considerations necessary to inform Global clinical development plans.
Participates in cross-functional teams to gather input for functional activities and ensures alignment.
Partners closely with other Insights and Analytics functions at the Global and Regional level (Market Research, Data Analytics, Competitive Intelligence).
Works closely with Global Commercial Development, Clinical Development, Portfolio Management, and Medical Affairs to support early-stage decision making.
Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future.
Reinforces market research best practices, identify market research and data sources, vendor options, and methodologies that are best suited to address a business need. May oversee day to day activities of or coordinate with third parties associated with this function.
Serves as a resource to identify, monitor, and track key business drivers.
Required Skills, Experience and Education:
Bachelor's degree required (MBA preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a strategic analytics role.
Experience supporting pipeline and portfolio decision making.
Extensive primary research and secondary analytical skills required; ability to translate the data and learning into actionable recommendations for business growth.
Experience conducting and coordinating of market research in regions outside the U.S.
Track record of being a collaborative team player, and adaptive to meet the needs of a growing business.
Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships.
Demonstrated ability to influence cross functional partners and contribute to discussions with senior management.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well with internal and external stakeholders, including strong interpersonal skills including verbal and written communication.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.
Preferred Skills:
Experience with targeted oncolytics.
Demonstrated ability to synthesize complex information and support and contribute to decision-making discussions.
Proven experience in a smaller, rapidly growing, company.
#LI-Remote #LI-JW1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Director, European Pricing & Market Access serves as the regional pricing leader and European pricing voice for Revolution Medicines. This incumbent will be a senior member of the European Market Access Leadership Team and acts as the dedicated European pricing strategist, providing rapid-response pricing scenario capability at product, indication, and portfolio level to support negotiations, pricing governance, and enterprise strategic planning.
The incumbent is accountable for maximizing European value realization while safeguarding long-term global price integrity across the RevMed portfolio. Operating at the intersection of regional execution and global pricing governance, this leader ensures European market dynamics, international reference pricing (IRP) implications, and health technology assessment (HTA) requirements are fully integrated into global pricing architecture and decision-making.
The Senior Director partners closely with Country Senior Directors, Market Access, as well as HEOR, Commercial, Regulatory, Finance, and Global Pricing colleagues, serving as the primary European interface to Global Pricing on all matters related to European pricing strategy. They will be based in Switzerland.
Key responsibilities:
Deliver rapid European pricing scenario analyses to support pricing governance decisions, payer negotiations, and competitive response, with accountability for analytical rigor, strategic relevance, and executive decision-readiness.
Own and maintain the European IRP simulation model, tracking basket compositions, referencing rules, revision timing, and exposure across 25+ markets.
Develop European price corridor recommendations, floor prices, and launch sequencing strategies based on IRP dynamics, HTA timelines, and competitive context.
Quantify the European revenue impact of proposed global pricing decisions and proactively shape recommendations to optimize regional and global value outcomes.
Model pricing implications of indication expansions, including MFN/IRP effects on base business and cross-indication value trade-offs.
Analyze portfolio pricing interdependencies and positioning implications across European markets.
Balance long-term franchise value against individual product optimization, acting as a steward of portfolio-level value across current and future indications.
Coordinate with Country Senior Directors, Market Access to provide pricing scenarios supporting live payer negotiations and guide strategic positioning during critical negotiation inflection points.
Translate country-level pricing intelligence into European and global strategic insights.
Support country teams with alternative pricing corridor scenarios when negotiations reach impasse.
Provide leadership, mentorship, and strategic guidance to country and regional pricing colleagues, fostering consistent pricing excellence across European markets.
Represent the European pricing perspective in global pricing governance forums and committees, serving as the accountable regional leader for European pricing inputs into enterprise decision-making.
Partner with the Executive Director, Global Pricing on pricing methodology, tools, and governance frameworks.
Provide European input into global price architecture, launch sequencing, and portfolio pricing decisions.
Represent European Pricing & Market Access in relevant enterprise governance, portfolio, and risk management forums.
Own and oversee the operational maintenance of the European pricing database as the single source of truth for list and net prices, including governance, audit trails, and documentation of price changes in alignment with global pricing standards and financial controls.
Monitor competitor pricing moves, reimbursement decisions, and tender outcomes across European markets.
Track European pricing policy changes, reforms, and implications of EU Joint Clinical Assessment (JCA) implementation.
Maintain expert-level knowledge of IRP/MFN mechanics and HTA-driven pricing dynamics across key European markets.
Translate external pricing and policy developments into forward-looking strategic implications for RevMed’s European and global pricing strategy.
Required Skills, Experience and Education:
Bachelor’s degree required; advanced degree (MBA, MSc, PhD, PharmD) in health economics, finance, life sciences, or related field preferred.
12–15+ years of progressive experience in pharmaceutical or biotech pricing, market access, or health economics, including leadership across multiple European markets within a complex matrix organization.
Deep expertise in European pricing and reimbursement environments, including MFN/IRP mechanics across major markets.
Demonstrated experience with European HTA processes (e.g., NICE, G-BA, HAS, AIFA) and their pricing implications.
Advanced analytical and financial modeling capabilities; experience with pricing intelligence platforms (e.g., IQVIA Pricentric, GlobalData).
Proven ability to partner effectively with Finance to translate complex pricing agreements and commercial terms into accurate financial treatment, including oversight of gross-to-net revenue adjustments.
Strong executive presence with demonstrated ability to influence senior and executive-level stakeholders.
Experience operating in a fast-paced, entrepreneurial biotech environment.
Oncology, rare disease, or specialty therapeutics experience preferred.
Preferred Skills:
Experience building or scaling pricing capabilities in a pre-commercial or early-commercial biotech organization.
Familiarity with EU Joint Clinical Assessment (JCA) regulation and Most Favoured Nation (MFN) and their impact on pricing strategy.
Multilingual capability (German, French, or other European languages advantageous).
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com. #LI-Remote #LI-LO1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Senior Project Coordinator will be part of the Commercialization Effectiveness and Operations (CE&O) team. The role is essential to the execution and achievement of goals and objectives of the CE&O, Global Commercial Development and Global Market Access teams taking on accountability for project execution and logistical coordination across leadership and team members including:
Provides project planning and executional support for key events, activities and initiatives. Might need to travel for large events to ensure program components, materials, stakeholders, timelines and logistics are aligned for successful execution.
Leads meeting support, coordinates logistics, and partners with functional leaders in creation, preparation, organization and communication of key meeting materials for key meetings.
Serves as a coordination point across various stakeholders including leaders and team members at all levels, cross functional business partners and external vendors/ agencies.
Establishes processes, timelines and milestones to plan and execute on key team events and initiatives. Flags gaps, inefficiencies, and risks in existing processes, and proposes solutions and improvements.
Partners with Commercial Development Operations team members to plan agendas and executes Commercial Development functional team and Cross functional leadership and workstream meeting along with External events (i.e., speaker series, ad boards, KOL meetings).
Partners with the Administration team members to plan and coordinate domestic and international travel including flights, VISA applications, travel documents, car transport, hotel bookings, restaurant reservations and other travel related needs of senior leaders as needed; this may require evening or weekend support, depending on the travel requirements.
Handles recruitment and onboarding activities including, more complex candidate interview scheduling for the functions supported, as well as management 1st day of new hire planning for the cohorts of sales new hires with HR and hiring manager. Maintains project, event and training documentation, timelines and trackers to ensure transparency and compliance.
Partners with Administration team members to coordinate expense report processing and reconciliation of receipts and credit card statements for senior leaders as needed.
Provides presentation slides support: consolidation, formatting, content organization as requested.
Works with Contract Administration team and business partners to coordinate consulting and/or master service agreements in partnership with legal to ensure they are in place and executed properly, including within approval limits, to support functional groups.
Fosters an open, inclusive, and collaborative culture. Partners with other Operations teams and Administration team members to find synergies across activities.
Required Skills, Experience and Education:
Bachelor’s degree required with 10+ years of progressive experience in event planning, project coordination, program management, operations or similar roles, of which 3+ years in biopharma or life sciences.
Familiarity with cross functional work within biotech/pharma and working across regions.
Exhibits impeccable integrity and sound judgment to handle highly sensitive and confidential material and information.
Strong organizational, project and time management skills; detail oriented and ability to manage multiple deliverables.
Ability to prioritize, multi-task with minimal direction.
Ability to collaborate with multiple stakeholders across field teams, cross functional partners, and/or external vendors.
Ability to navigate organizational complexities and seek solutions for continuous improvement
Ability to influence without authority and drive progress across teams.
Willingness to support Revolution Medicines to succeed by thinking outside of the box and job description.
Able to adapt to changes in the work environment.
Professional demeanor and team-player while maintaining positive, team-focused attitude.
Proactive and excellent self-initiative.
Excellent verbal and written communication skills.
Proficient with MS Word, Excel, PowerPoint, and Outlook calendar.
Preferred Skills:
Experience with applicant tracking systems highly preferred.
Familiarity with commercial or commercialization environment in biotech/pharma.
Experience with project management tools, (i.e. SmartSheet) and communications platforms (i.e., Teams portal development, newsletters) is a plus.
#LI-Remote #LI-JW1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting to the VP, Global Commercial Development Disease Area Lead, this newly created role will serve as a leader for continuing to build our global oncology marketing capabilities driving global commercial strategy at product team. Candidates should be passionate about leading cross-functional collaboration and contributing as both a strategic leader and hands-on driver in a growing organization. This position is primarily remote with travel required for scientific and team meetings.
Specifically, you will be responsible for:
Partner across the company including with clinical development, medical affairs, market access, to drive indication strategy, shape brand strategies across the product team.
Ensure global readiness to drive successful launch planning, commercialization, and performance tracking across the U.S. and key ex-U.S. markets.
Execute global disease area strategy, brand strategies, including branding, positioning, messaging, and value propositions that guide regional affiliates and align with long-term portfolio goals.
Lead commercial assessments and commercial development guidance for programs in early-stage development, build cross-functional relationships with early pipeline teams, and develop new ways of working for Global Commercial Development’s support of the early portfolio.
Translate scientific and market insights into compelling strategies, launch narratives, and execution plans; effectively communicating recommendations and leading strategic discussions with global and regional stakeholders.
Develop and refine global brand plans, including revenue and patient forecasts, to inform investment decisions, lifecycle strategies, and portfolio prioritization.
Drive excellence in global launch execution: creating launch frameworks, ensuring best practices are shared across affiliates, and monitoring progress to anticipate and resolve challenges.
Identify and manage external agencies, vendors, and partners to deliver impactful global campaigns, educational initiatives, and engagement platforms.
Serve as a trusted resource to senior leadership in identifying opportunities to maximize commercial value, expand indications, and differentiate in competitive markets.
Bring innovation and new capabilities to global marketing—collaborate with IS Commercial to integrate digital, omnichannel, and data-driven approaches to build a best-in-class commercial function.
Up to 50% of travel required.
Required Skills, Experience and Education:
Bachelor’s degree required with at least 15 years or advanced degree with at least 8 years of progressive commercial experience in a biotechnology and/or pharmaceutical company including strategic marketing and ideally sales.
Proven success of developing and executing global commercial strategy.
Demonstrated ability to derive insights/analytics leading to the development of innovative commercial strategies.
Strong leadership, with the ability to lead teams, work well cross-functionally, and influence across the organization to create a clear sense of direction.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Strong clinical and scientific acumen with proven ability to translate pre-clinical and clinical data into downstream commercial implications
Ability to represent Revolution Medicines well externally: strong interpersonal skills including verbal and written communication.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.
Preferred Skills:
Experience in leading the global launch of new product in competitive spaces
Experience with an oncology launch is desired.
Prior experience in a smaller, rapidly growing, company.
Experience in gastrointestinal or lung cancer preferred.
#LI-Hybrid #LI-JW1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting to the VP, Global Commercial Development Disease Area Lead, this newly created role will serve as a leader for continuing to build our global oncology marketing capabilities driving global commercial strategy at product team and overseeing global launch strategy and lifecycle planning for a given indication/indications. Candidates should be passionate about leading cross-functional collaboration, and contributing as both a strategic leader and hands-on driver in a growing organization. This position is primarily remote with travel required for scientific and team meetings.
Specifically, you will be responsible for:
Partner across the company including with clinical development, medical affairs, market access, to drive indication strategy, shape brand strategies across the product team.
Ensure global readiness to drive successful launch planning, commercialization, and performance tracking across the U.S. and key ex-U.S. markets.
Execute global disease area strategy, brand strategies, including branding, positioning, messaging, and value propositions that guide regional affiliates and align with long-term portfolio goals.
Translate scientific and market insights into compelling strategies, launch narratives, and execution plans; effectively communicating recommendations and leading strategic discussions with global and regional stakeholders.
Develop and refine global brand plans, including revenue and patient forecasts, to inform investment decisions, lifecycle strategies, and portfolio prioritization.
Drive excellence in global launch execution: creating launch frameworks, ensuring best practices are shared across affiliates, and monitoring progress to anticipate and resolve challenges.
Identify and manage external agencies, vendors, and partners to deliver impactful global campaigns, educational initiatives, and engagement platforms.
Serve as a trusted resource to executive leadership in identifying opportunities to maximize commercial value, expand indications, and differentiate in competitive markets.
Bring innovation and new capabilities to global marketing—collaborate with IS Commercial to integrate digital, omnichannel, and data-driven approaches to build a best-in-class commercial function.
Up to 50% of travel required.
Required Skills, Experience and Education:
Bachelor’s degree required (MBA preferred) with at least 15+ years of progressive commercial experience in a biotechnology and/or pharmaceutical company including strategic marketing and ideally sales.
Proven success of developing and executing global marketing strategy.
Experience in leading the global launch of new product in competitive spaces.
Demonstrated ability to derive insights/analytics leading to the development of innovative marketing strategies.
Strong leadership, with the ability to lead teams, work well cross-functionally, and influence across the organization to create a clear sense of direction.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well externally: strong interpersonal skills including verbal and written communication.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.
Preferred Skills:
Experience with an oncology launch is desired.
Prior experience in a smaller, rapidly growing, company.
Experience in gastrointestinal or lung cancer preferred. #LI-Hybrid #LI-SS2
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting directly to the Senior Director, Global Insights, the Director, Global Insights role requires strategic thinking and expertise to provide critical contributions to disease area strategy, life-cycle planning and product and portfolio decisions. The individual in this role will be responsible for conducting market research in a variety of geographies to help support the development and potential commercialization of the RevMed portfolio and will be an influential voice in developing asset strategy. The ideal candidate will have experience working on pipeline molecules in Oncology across multiple geographies, strong problem-solving skills, a strategic mindset, and will exhibit curiosity, flexibility, and be comfortable with ambiguity.
This position would ideally be based at our headquarters in Redwood City, CA., however open to remote candidates who are willing to travel to our CA office on a regular basis.
Responsibilities include:
Works cross functionally to develop and execute the global insights roadmap in support of current business needs and future opportunities across the portfolio of targeted oncology molecules.
Translates insights into strategic recommendations to inform and influence global business decision making.
Communicates strategic insights from market research to drive critical business decisions and strategy.
Initiates and facilitates activities that enhance organizational knowledge regarding the relevant market and potential product attributes, usage, market dynamics, and competition.
Communicates and aligns key internal stakeholders around market research and analytics objectives and outputs including qualifying the results based on the strength of the data and identifying limitations.
Develops and presents actionable recommendations to key stakeholders, focusing on key findings and relevant implications to each stakeholder group, and senior leadership.
Researches, analyzes, and formulates insights on complex markets, various disease states, competitive landscapes, and relevant market and managed care dynamics.
Synthesizes and communicates the similarities, differences, and considerations necessary to inform Global clinical development plans.
Participates in cross-functional teams to gather input for functional activities and ensures alignment.
Partners closely with other Insights and Analytics functions at the Global and Regional level (Market Research, Data Analytics, Competitive Intelligence).
Works closely with Global Commercial Development, Clinical Development, Portfolio Management, and Medical Affairs to support early-stage decision making.
Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future.
Reinforces market research best practices, identify market research and data sources, vendor options, and methodologies that are best suited to address a business need. Manages third parties associated with this function.
Serves as a resource to identify and tracking key business drivers.
Required Skills, Experience and Education:
Bachelor's degree required (MBA preferred) with 10+ years of progressive experience in a pharmaceutical, biotechnology, or strategic consulting role with 6+ years of experience in a strategic analytics role.
Experience supporting pipeline and portfolio decision making.
Extensive primary research and secondary analytical skills required; ability to translate the data and learning into actionable recommendations for business growth.
Experience conducting and coordinating of market research in regions outside the U.S.
Track record of being a collaborative team player, and adaptive to meet the needs of a growing business.
Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships.
Demonstrated ability to influence senior management and key business partners.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well with internal and external stakeholders, including strong interpersonal skills including verbal and written communication.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.
Preferred Skills:
Experience with targeted oncolytics.
Demonstrated ability to synthesize complex information and influence decision-making at the executive level.
Proven experience in a smaller, rapidly growing, company. #LI-Hybrid #LI-VN1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Associate Director, Global Pricing Strategy & Analytics will play a critical role in shaping and executing global pricing strategies across the portfolio. This individual will lead the development of pricing frameworks, provide advanced analytics, and generate insights to support value optimization and market access decisions. The role requires strong cross-functional collaboration with Market Access, Commercial, Finance, HEOR, and Regional teams to ensure pricing strategies are aligned with business objectives and external market dynamics.
Key Responsibilities:
Global Pricing Strategy
Support the development and execution of global pricing strategies for pipeline products across key markets.
Establish pricing guidance, guardrails, and launch sequencing strategies to optimize global value.
Evaluate pricing scenarios considering payer dynamics, competitive landscape, and regulatory constraints.
Support early asset strategy by integrating pricing considerations into clinical and commercial planning.
Analytics & Insights
Design and deliver advanced pricing and access analytics, including price-volume trade-offs, corridor analyses, and international reference pricing (IRP) impact.
Develop and maintain pricing models to inform decision-making at global and regional levels.
Generate insights from real-world data, market research, and analog products to support pricing decisions.
Monitor pricing performance and identify risks/opportunities post-launch.
Governance & Execution
Drive pricing governance processes, including global price approvals and exception management.
Ensure compliance with global pricing policies and external regulations.
Partner with regional and country teams to support local price setting and negotiations.
Cross-Functional Collaboration
Collaborate closely with Market Access, HEOR, Commercial, Finance, and Legal teams.
Align pricing strategies with value proposition, evidence generation, and reimbursement pathways.
Provide strategic input into business development opportunities, including licensing and acquisitions.
Capability Building
Develop global pricing infrastructure including systems, tools, and analytical platforms.
Contribute to the development of pricing frameworks, dashboards, and best practices.
Required Skills, Experience and Education:
Education & Experience
Bachelor’s degree required; advanced degree (MBA, MPH, PhD, PharmD, or equivalent) preferred.
6+ years of experience in pharmaceutical/biotech industry, with strong focus on pricing, market access, or commercial analytics.
Experience in global pricing strategy and launch pricing preferred.
Skills & Competencies
Deep understanding of global pricing, reimbursement systems, and payer dynamics.
Strong analytical and quantitative skills with experience in pricing modeling and data analysis.
Ability to translate complex data into clear strategic recommendations.
Excellent communication and stakeholder management skills.
Proven ability to work cross-functionally in a global, matrixed environment.
High level of business acumen and strategic thinking.
Preferred Skills:
Experience with oncology or specialty therapeutics.
Familiarity with international reference pricing (IRP), health technology assessment (HTA), and access pathways.
Experience supporting pipeline assets and early commercialization strategy.
#LI-Remote #LI-JW1
The base pay salary range for this full-time position is listed below. Please note that base pay salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities. In addition, some positions may include eligibility to earn commissions/bonus based on company and/or individual performance.
Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, incentive, field kit benefits, or any other form of compensation and field kit benefits that are allocable to a particular employee remains in the Company's sole and absolute discretion unless and until paid and may be modified at the Company’s sole and absolute discretion, consistent with applicable law.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Director, Global Value, Access & Pricing – CRC is responsible for developing and driving global access and pricing strategies for Revolution Medicines’ CRC assets to enable timely, sustainable patient access across key markets. This role ensures payer and HTA requirements are embedded into clinical development, indication sequencing, and launch planning from early-stage development through commercialization.
The Director serves as the global access lead on cross-functional asset teams and partners closely with HEOR, Clinical Development, Regulatory, Commercial, Finance, and Regional Market Access to align global strategy with regional execution.
Key responsibilities:
Lead development of global pricing and market access strategies for CRC assets, including launch sequencing, reference pricing considerations, and price corridor management across priority markets.
Identify payer-relevant evidence requirements and partner with HEOR to align evidence generation plans with global reimbursement needs.
Assess CRC competitive dynamics, including line-of-therapy positioning, biomarker-driven access considerations, and combination therapy reimbursement implications.
Guide EU Joint Clinical Assessment (JCA) strategy and submission preparation in collaboration with regional Market Access and HEOR teams.
Build and maintain strong relationships with Clinical, Commercial, Regulatory, HEOR, and Medical Affairs functions.
Provide strategic direction to regional teams on pricing implementation, reimbursement risk mitigation, and negotiation readiness.
Contribute to Global Market Access capability-building efforts to strengthen organizational knowledge and effectiveness.
Provide strategic market access input into clinical development programs to optimize endpoints, comparators, and evidence packages for payer and HTA success.
Monitor, analyze, and communicate global access and pricing trends, competitor activities, and policy changes.
Contribute access and pricing assessments to lifecycle planning and business development evaluations.
Required Skills, Experience and Education:
Bachelor’s degree required; advanced degree Ph.D., PharmD, MD, or MSc in Health Economics, Public Health, Health Policy, or a related field preferred.
10+ years of relevant experience in market access and pricing, ideally with global leadership exposure.
Strong experience in pricing & reimbursement of oncology products.
Deep understanding of global payer systems and HTA processes, including AMNOG, Chuikyo, NICE, and other EU frameworks.
Experience designing and implementing global pricing strategy, including value-based pricing, launch sequencing, and reference pricing mitigation.
Experience with pricing regulations, early pricing analysis, and pricing negotiations (country level experience preferred).
Demonstrated ability to support clinical development to satisfy payer/HTA evidence needs.
Experience engaging HTA and payer organizations in early advice to inform development and trial strategies.
Preferred Skills:
Strategic and analytical thinking with strong problem-solving skills.
Excellent communication, leadership, and cross-functional collaboration abilities.
Proven track record influencing decisions and driving results in a matrix organization.
Fluency in English; additional languages are a plus.
#LI-Remote #LI-JW1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
We are seeking an experienced IT Leader to establish and oversee the set up and execution of all aspects of IT operations in Japan. This role will serve as the primary technology partner for business functions in Japan, also acting as the bridge between local stakeholders and global Information Sciences (IS) and Information Technology (IT) teams ensuring that IS/IT needs are met in alignment with global platforms, delivering end-to-end solutions for local implementation while driving operational excellence in IS/IT services. This leader may also help build and scale the IT function to other countries in the Asia Pacific region through a balanced model of internal team development and strategic vendor partnerships to deliver agile, high-quality support across the region.
Reporting directly to the President & Representative Director, Japan, this individual will collaborate closely with country and regional leaders as well as global Information Sciences and Information Technology (IS/IT) partners. The role also dotted-line reports to the VP, Commercial & Medical Affairs Information Systems. The position requires versatility—balancing the establishment of local capabilities with the development of scalable solutions that integrate seamlessly into global frameworks.
Commercial and Medical Affairs Systems
Serve as the primary liaison between Japan and global Information Systems teams, fostering cross-functional collaboration while maintaining data governance and separation of processes.
Partner with business leaders to develop prioritized roadmaps and capture requirements, ensuring alignment with global IS/IT platform roadmaps while tailoring solutions to country/regional needs.
Act as an effective liaison by proactively communicating priority needs for the APAC/Japan region and working closely with other regions to align on shared priorities, expectations, and consistent working norms.
Support rollout, localization, and adoption of global platforms (e.g., CRM, digital engagement, Omnichannel marketing, medical information, medical content management, field engagement tools).
Partner with local Commercial, Supply Chain and Quality teams to ensure IS/IT systems supporting product distribution, logistics, and product release operate reliably and comply with local regulatory standards.
Oversee localization and validation of IS/IT systems to meet Japan-specific business and regulatory needs, including language, documentation, and integration with local platforms.
Provide Tier 1–2 application support in partnership with global support teams, ensuring seamless end-to-end service delivery.
Lead change management for new IS/IT systems, including user testing, training, communications, and stakeholder alignment to ensure successful adoption and continuous improvement.
Information Technology and Security
Establish and manage relationships with local managed service providers and vendors.
Collaborate with global IT infrastructure teams to ensure reliable and secure delivery of core IT services (network, hardware, collaboration platforms, endpoint management).
Oversee system enhancements, integrations, and facilitate compliance with Japanese data production and pharmaceutical regulations, including pharmacovigilance, promotional review, and data privacy (APPI, PMD Act).
Manage onboarding and offboarding processes, ensuring timely provisioning/deprovisioning of accounts and devices aligned with local and global IT policies and security standards.
Ensure adherence to global IT service management and change control processes, including incident, request, and problem management, while coordinating escalations with global support teams.
Partner with global Information Security teams to ensure adherence to enterprise security standards, policies, and regulatory requirements.
Lead Japan-specific implementation and oversight of security controls—including identity and access management, data protection, compliance monitoring, cybersecurity training, audits, and incident response coordination with global security operations.
R&D Systems:
Partner with global R&D IS to enable secure access to research and clinical platforms in compliance with regulatory requirements (GxP, CTMS, EDC, RIM, eCTD, PV safety database, etc).
Required Skills, Experience and Education:
Bachelor’s degree (or equivalent).
Minimum of 12 years of experience delivering technology services and support, including Commercial systems.
At least 5 years of experience leading Japan IT activities within a life sciences organization.
Proven leadership experience building and scaling IT teams in emerging country operations, including recruitment, performance management, and fostering a culture of accountability and continuous improvement.
Hands-on knowledge of IT infrastructure, end-user services, and cybersecurity practices.
Strong understanding of Commercial data ecosystems (CRM, digital engagement, social, and third-party sources) and their integration across platforms.
Knowledge of master data management (MDM), data warehousing principles and technologies, and enterprise analytics environments (e.g., Databricks, Snowflake), supporting Commercial and Medical insights.
In-depth knowledge of GxP systems, regulatory, compliance, and data privacy frameworks and processes.
Experienced in leading organizational change for IT initiatives, driving user adoption through clear communication, stakeholder alignment, and compelling storytelling.
Collaborative and effective in building rapport across global, regional, local, and functional teams.
Comfortable with ambiguity and skilled at defining operating models, processes, and roles while simultaneously implementing capabilities.
Preferred Skills:
Experience supporting pre-commercial or commercial launches in pharma strongly preferred.
Familiarity with Omnichannel principles and technology platforms in life sciences.
Experience with an Oncology launch is desired.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
Reporting directly to the Executive Director, Global Analytics and Insights, the Competitive Intelligence role requires strategic thinking and expertise to provide critical contributions to brand strategy, launch and life-cycle planning, forecasting, and product and portfolio decisions. This role involves providing comprehensive strategic and competitive insights to support decision-making and strategy-setting across various development programs. The ideal candidate will play a crucial role in monitoring and evaluating the competitive landscape, conducting comprehensive threat assessments, and collaborating with key stakeholders to inform strategic planning. This position would ideally be based at our headquarters in Redwood City, CA., however open to remote candidates who are willing to travel to our CA office on a regular basis.
Responsibilities Include:
Conducts thorough competitive and market assessments to identify market dynamics, trends, and potential impacts on Revolution Medicines’ pipeline, delivering insights to key stakeholders.
Collaborates with stakeholders across the company (including Commercial, Medical Affairs, and R&D) to integrate internal and external information, analytics, and data.
Coordinates and execute coverage of key medical congresses; outputs may include daily and post-conference summaries and post-conference summary presentations.
Maintains an in-depth understanding of Revolution Medicines’ diverse product offerings, competitive positioning, and the broader market dynamics shaping the industry's future.
Benchmarks competitor clinical data, business models and capabilities.
Translates insights into strategic recommendations to inform and influence decision making and strategy setting.
Proactively facilitates the identification and prioritization of intelligence efforts critical to strategic planning and execution for key stakeholders; provides direction for the design and refinement of intelligence plans.
Reinforces Competitive Intelligence best practices, identifies secondary data sources, vendor options, and methodologies that are best suited to address a business need. Manages third parties associated with this function.
Participates in cross-functional teams to gather input for functional activities and to ensure alignment.
Consistently and effectively communicates with key stakeholders in a timely manner to inform on critical updates.
Required Skills, Experience and Education:
Minimum of 8 years experience in competitive intelligence, market research, or a related field within the pharmaceutical and/or biotechnology industry.
Demonstrated leadership, influencing skills, creativity, problem solving and ability to manage complexity.
Experience in new product launches and pre-launch environments.
Track record of being a collaborative team player, and adaptive to meet the needs of a growing business.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients.
Preferred Skills:
Advanced degree (PhD, Master’s) preferred.
10+ years of experience in competitive intelligence with focus in Oncology.
Demonstrated ability to synthesize complex information and influence decision-making at the executive level.
#LI-Remote #LI-JW1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Share this job
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
This is a rare and highly visible opportunity to help build something new at a pivotal moment in Revolution Medicines’ growth. We are seeking an experienced and highly collaborative Senior Director, Commercial Project Management to play a foundational role in establishing and scaling global commercial project management as a core capability within the global commercialization organization. This role sits within the newly formed Commercialization Effectiveness & Operations (CE&O) function and will be instrumental in translating commercial strategy into disciplined, high‑impact execution across a diverse portfolio of global commercial and commercialization initiatives.
You will partner closely with Global Commercial Leads and cross‑functional stakeholders to lead complex, high‑impact global Commercial Project Teams — translating strategy into aligned plans, accelerating execution, and strengthening how we work as we scale.
Operating in a build‑while‑scaling environment, this leader will help shape how complex, cross‑functional work gets done—bringing clarity, structure, and momentum while partnering closely with global commercial leadership and cross‑functional stakeholders. The role is intentionally designed for someone who thrives in ambiguity, is energized by creating fit‑for‑purpose ways of working, and is motivated by the opportunity to leave a lasting imprint on how the organization operates. As the capability matures, this role is expected to grow into people leadership and broader sub‑functional ownership.
What You’ll Do
Lead cross‑functional Global Commercial Project Teams in close partnership with Global Commercial Leads, driving clarity, alignment, and progress across priorities and interdependencies.
Own end‑to‑end project execution for a portfolio of high‑priority global commercial and commercialization initiatives (e.g., readiness planning, major commercial initiatives, capability build‑outs), ensuring milestones, risks, and dependencies are visible and managed.
Coordinate and integrate inputs across Commercial, Medical, Market Access, Regulatory, Supply/Tech Ops, Legal, Finance, and other partners into cohesive global commercial plans and decision‑ready updates.
Proactively identify risks and remove blockers, driving trade‑offs and timely decisions through strong stakeholder leadership and executive communication.
Help build and scale global commercial project management capability (tools, templates, dashboards, project rhythms) in partnership with the broader CE&O team — bringing practical structure without over‑engineering.
Support governance and ways of working by partnering with CE&O colleagues and functional leaders to strengthen decision‑making, accountability, and escalation paths (shared ownership).
Drive continuous improvement and change adoption across projects by capturing learnings, simplifying processes, and strengthening execution discipline.
Who You Are
You’re energized by building in ambiguity and thrive when the work is complex and cross‑functional. You bring the right balance of rigor and pragmatism, can influence without authority, and communicate with clarity from working teams through executives. You’re excited to help shape how a global commercial organization operates — not just run individual projects.
Required Skills, Experience and Education:
Bachelor’s degree, with 12+ years of relevant experience in biotech/pharma/healthcare, including significant experience leading complex, cross‑functional commercial or commercialization initiatives.
Experience supporting global commercial organizations, including launch readiness, lifecycle management, or major commercialization initiatives.
Experience working across regions and global/local operating models.
Demonstrated Senior Director‑level capability: ability to shape scalable practices, lead through influence, and drive change in evolving organizations.
Strong project leadership skills: planning, dependency/risk management, stakeholder leadership, and executive‑ready communication.
Proven success partnering with senior commercial leaders and leading execution across functions without direct authority.
Track record of thriving in ambiguous, fast‑moving environments with a roll‑up‑your‑sleeves mindset.
Exceptional communication and interpersonal skills, with the ability to translate complexity into clarity for diverse audiences.
Strong judgment, systems thinking, and a solutions‑oriented mindset.
Preferred Skills:
Advanced degree (MBA/MS/PhD).
Oncology / specialty pharma commercialization experience.
Formal Project Management training or certification (e.g., PMP).
Early people leadership experience or readiness to step into people leadership as the capability scales.
#LI-Remote #LI-JW1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
Ready to apply?
Apply to Revolution Medicines
Cookies & analytics
This site uses cookies from third-party services to deliver its features and to analyze traffic.